What's Happening

Search Results

There are 6 item(s) tagged with the keyword "PrEP".

1. Losing the Phobia: HIV PrEP is Bridging the Serodivide

By Ifeoma Udoh, PhD | September 27, 2018
Senior Research Associate, ETR

Access to PrEP is changing minds and behaviors. As an HIV prevention option, PrEP (pre-exposure prophylaxis for HIV) has provided individuals who may be at risk for HIV an important tool in the way they conceptualize choices about sex partners.

The practice of serosorting—selecting a sexual partner based on HIV status—has often been seen as either stigmatizing or divisive. However, PrEP is changing this practice among both older and younger men who have sex with men (MSM). I contributed to a just-published paper that demonstrates this in some persuasive ways.

Tags: Equity, Stigma, PrEP, HIV prevention, HIV
By Ifeoma Udoh, PhD

2. Keep Moving Forward: Responding to High STD Rates

By Marcia Quackenbush, MS, MFT, MCHES | November 10, 2016
Senior Editor, ETR

STD rates are up. The CDC noted in a recent press release that reported STDs are at an “unprecedented high” in the U.S.

This sort of news is undeniably discouraging for those of us working the sexual and reproductive health arena. After all, we’ve been feeling rather upbeat and hopeful about the impressive drop in unplanned teen pregnancies—rates are down more than half over the past 20 years. 

Tags: STDs, STD prevention, PrEP, Science
By Marcia Quackenbush, MS, MFT, MCHES

3. PrEP Gives Us More

By Jim Pickett | October 11, 2016
Director of Prevention Advocacy and Gay Men's Health, AIDS Foundation of Chicago

PrEP has altered the landscape in HIV prevention in extraordinary and profound ways. It’s changing the lives of vulnerable individuals. It’s also bringing about big changes for the HIV workforce—health care providers, prevention specialists, outreach workers, social workers, educators and more. In fact, I believe we’ve entered the most dynamic period in our fight against HIV since 1996, when the advent of highly active antiretroviral therapy revolutionized treatment and saved countless lives.

Tags: HIV-AIDS, PrEP, HIV, HIV prevention

4. Currently Exploring: Answers--and Questions--About PrEP

By Marcia Quackenbush, MS, MFT, MCHES | September 6, 2016
Senior Editor, ETR

In 2012, the U.S. Food and Drug Administration approved oral Truvada for pre-exposure prophylaxis of HIV (PrEP). In a very short period of time, PrEP has substantially changed the HIV prevention landscape. It’s effective (when taken) and has an excellent safety profile.

How well is it working in different populations? I took a quick dive into some recent reports to get an update.

Tags: HIV-AIDS, HIV, HIV prevention, PrEP
By Marcia Quackenbush, MS, MFT, MCHES

5. Now in Spanish – Using PrEP to Prevent HIV

By Laura Perkins, MLS | February 18, 2016
Project Editor, ETR

The Hispanic/Latino community is disproportionately affected by HIV. In 2013, Hispanics/Latinos accounted for 21% of the estimated new diagnoses of HIV infection in the U.S., despite representing about 17% of the total population.

We recently reported how pleased we are that ETR has a new pamphlet on PrEP (pre-exposure prophylaxis) to prevent HIV. Well, now we're especially thrilled to offer our new title on PrEP in Spanish.

Tags: HIV-AIDS, HIV, PrEP, Community Impact Solutions Project

6. PrEP--Expanding the HIV Prevention Toolkit

By Laura Perkins, MLS | December 4, 2015
Project Editor, ETR

PrEP (pre-exposure prophylaxis) for HIV means taking a combination pill to prevention transmission of the virus. The pill, brand name Truvada, has proved to be successful at protecting at-risk individuals. Trials evaluating PrEP among gay and bisexual men, heterosexual men and women, and injection drug users indicate that the risk of getting HIV decreased by up to 92% for participants who took the medicine consistently.

This is phenomenal!

Tags: HIV-AIDS, HIV, PrEP, New products, Community Impact Solutions Project

Displaying: 1 - 6 of 6

Our e-newsletters bring you the best of our blog each month.

Social Media :

  • YouTube
  • LinkedIn
  • Twitter
  • Facebook